Literature DB >> 15246126

Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study.

M Kulig1, M Nocon, M Vieth, A Leodolter, D Jaspersen, J Labenz, W Meyer-Sabellek, M Stolte, T Lind, P Malfertheiner, S N Willich.   

Abstract

OBJECTIVE: We describe the design and report the first results of the Progression of Gastroesophageal Reflux Disease (ProGERD) study, to our knowledge the largest prospective study of GERD patients. STUDY DESIGN AND
SETTING: Patients were recruited at 1,253 centers in Germany, Austria, and Switzerland. Following an assessment of medical history, all patients were endoscoped and received esomeprazole for 2 to 8 weeks before entering the 5-year observational phase.
RESULTS: A total of 6,215 patients (53% male, age 54+/-14) were included. Of these patients, 46% reported at least daily symptoms, 15% were unable to work at least once during the prior year, and 71% had visited a physician due to reflux symptoms. Barrett's esophagus (BE) was found in 11% of our GERD patients. In polychotomous regression analysis, the main factors related to the occurrence of the three GERD subgroups (nonerosive, erosive disease, and BE) were age, gender, duration of GERD, body mass index (BMI), smoking, and previous PPI use. Factors associated with longer disease duration were increasing age, male gender, BMI, increasing symptom severity, presence of erosive GERD or BE, positive family history, and smoking.
CONCLUSION: The findings indicate that GERD is a great burden for patients, and has significant socioeconomic implications. The long-term follow-up period with further endoscopic and histologic evaluations, will help further our understanding of the natural course of the disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15246126     DOI: 10.1016/j.jclinepi.2003.10.010

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  37 in total

Review 1.  The role of obesity in oesophageal cancer development.

Authors:  Elizabeth Long; Ian L P Beales
Journal:  Therap Adv Gastroenterol       Date:  2014-11       Impact factor: 4.409

Review 2.  Treatment of uncomplicated reflux disease.

Authors:  Joachim Labenz; Peter Malfertheiner
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

Review 3.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

4.  Gastro esophageal reflux disease is associated with absence from work: results from a prospective cohort study.

Authors:  Andreas Leodolter; Marc Nocon; Michael Kulig; Stefan N Willich; Peter Malfertheiner; Joachim Labenz
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 5.  Risks of combined alcohol/medication use in older adults.

Authors:  Alison A Moore; Elizabeth J Whiteman; Katherine T Ward
Journal:  Am J Geriatr Pharmacother       Date:  2007-03

Review 6.  Screening and surveillance of Barrett's esophagus.

Authors:  Jeff Michalak; Ajay Bansal; Prateek Sharma
Journal:  Curr Gastroenterol Rep       Date:  2009-06

7.  Comparison of reflux esophagitis and its complications between African Americans and non-Hispanic whites.

Authors:  Kenneth J Vega; Sian Chisholm; M Mazen Jamal
Journal:  World J Gastroenterol       Date:  2009-06-21       Impact factor: 5.742

8.  Outcome of laparoscopic Nissen fundoplication in patients with body mass index >or=35.

Authors:  M Anvari; F Bamehriz
Journal:  Surg Endosc       Date:  2005-12-06       Impact factor: 4.584

9.  The pathophysiological mechanisms of GERD in the obese patient.

Authors:  Ronnie Fass
Journal:  Dig Dis Sci       Date:  2008-07-29       Impact factor: 3.199

10.  Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: a prospective intervention trial.

Authors:  Mandeep Singh; Jaehoon Lee; Neil Gupta; Srinivas Gaddam; Bryan K Smith; Sachin B Wani; Debra K Sullivan; Amit Rastogi; Ajay Bansal; Joseph E Donnelly; Prateek Sharma
Journal:  Obesity (Silver Spring)       Date:  2013-02       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.